Royal Bank of Canada
NPCE icon

Royal Bank of Canada’s Neuropace NPCE Stock Holding History

Royal Bank of Canada’s Portfolio NPCE Stock Details NPCE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$198K Sell
15,055
-423
-3% -$6.35K ﹤0.01% 4722
2025
Q4 		$239K Sell
15,478
-14,325
-48% -$192K ﹤0.01% 4658
2025
Q3 		$308K Buy
29,803
+21,831
+274% +$206K ﹤0.01% 4814
2025
Q2 		$88K Buy
7,972
+6,228
+357% +$77.9K ﹤0.01% 5682
2025
Q1 		$22K Buy
1,744
+998
+134% +$12.5K ﹤0.01% 5882
2024
Q4 		$8K Sell
746
-1,074
-59% -$9.34K ﹤0.01% 6409
2024
Q3 		$13K Buy
1,820
+537
+42% +$3.93K ﹤0.01% 6264
2024
Q2 		$10K Buy
+1,283
New +$12.9K ﹤0.01% 6342
2024
Q1 		– Sell
-118
Closed -$1K – 7402
2023
Q4 		$1K Buy
118
+114
+2,850% +$909 ﹤0.01% 6955
2023
Q3 		$0 Sell
4
-337
-99% -$1.97K ﹤0.01% 7403
2023
Q2 		$2K Buy
+341
New +$1.54K ﹤0.01% 6892
2023
Q1 		– Sell
-58
Closed – – 7341
2022
Q4 		$0 Sell
58
-171
-75% -$380 ﹤0.01% 7553
2022
Q3 		$1K Buy
229
+81
+55% +$390 ﹤0.01% 7227
2022
Q2 		$1K Sell
148
-288
-66% -$1.9K ﹤0.01% 7162
2022
Q1 		$4K Sell
436
-1,292
-75% -$11.1K ﹤0.01% 7328
2021
Q4 		$17K Buy
1,728
+894
+107% +$11.6K ﹤0.01% 6864
2021
Q3 		$13K Buy
834
+357
+75% +$7.5K ﹤0.01% 6873
2021
Q2 		$11K Buy
+477
New +$11.1K ﹤0.01% 6842

Other funds holding NPCE

PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Royal Bank of Canada's NPCE Position: Q1 2026 in Review

Royal Bank of Canada reduced its Neuropace (NPCE) stake by 2.7% in Q1 2026, selling an estimated $6.35K and leaving 15,055 shares worth $198K. The position accounts for ﹤0.01% of the portfolio, ranked #4722.

Royal Bank of Canada first reported a position in NPCE in Q2 2021 and has held it in 18 quarters since. The position peaked at $308K in Q3 2025. 113 funds tracked by Wall St. Rank hold NPCE as of Q1 2026.

  • Royal Bank of Canada held 15,055 shares of Neuropace worth $198K as of Q1 2026.
  • Royal Bank of Canada sold 423 Neuropace shares in Q1 2026, an estimated $6.35K.
  • Neuropace made up ﹤0.01% of Royal Bank of Canada's portfolio in Q1 2026, its #4722 holding.
  • Royal Bank of Canada first reported a position in Neuropace in Q2 2021 and has held it in 18 quarters since.
  • Royal Bank of Canada's Neuropace position peaked at $308K in Q3 2025.
  • 113 funds tracked by Wall St. Rank held Neuropace as of Q1 2026.

Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.